Atezolizumab, a PD-L1 Inhibitor: An Association of Bleeding Gastric Ulcer With Its Use.

Bapatla, Anusha; Tariq, Tooba; Haider, Maryam Bilal; Mohamad, Bashar

Bapatla, Anusha; Tariq, Tooba; Haider, Maryam Bilal; Mohamad, Bashar.

Afiliación

Bapatla A; Internal Medicine, Detroit Medical Center-Sinai Grace Hospital, Wayne State University, Detroit, USA.
Tariq T; Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Haider MB; Gastroenterology and Hepatology, Wayne State University, Detroit, USA.
Mohamad B; Internal Medicine, Detroit Medical Center-Sinai Grace Hospital, Detroit, USA.

Cureus ; 13(6): e15637, 2021 Jun 14.

Article en En | MEDLINE | ID: mdl-34150414

Palabras clave

atezolizumab; gastric ulcer; gastrointestinal manifestations; immune check point inhibitors; upper gastrointestinal manifestations

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Cureus Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google